Oropharyngeal Cancer Up in Young Patients
Head and neck cancers have increased 60% since 1973.
Head and neck cancers have increased 60% since 1973.
In plasma samples obtained prior to diagnosis, the presence of human papillomavirus type 16 E6 antibodies was more likely to be detected in patients with oropharyngeal cancer than in controls.
The incidence of HPV-negative oropharyngeal cancers (OPC) is in decline, but rates of HPV-positive OPC are increasing with no sign of abating.